Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by opjohn1on Oct 02, 2018 12:43pm

99 Views

Post# 28729933

Management.....

So when will management update us on ANYTHING ? I am somewhat new to TLT but when are the Q3 financials going to out ? and who will have a CC to discuss progress both financial and medical ?

I can wait on PH2 completion but doing so blind is becoming a real challenge. :-(

Bullboard Posts

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload